These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in hormonal therapy for advanced prostate cancer. Oottamasathien S; Crawford ED Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672 [TBL] [Abstract][Full Text] [Related]
10. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
11. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the treatment of metastatic prostate cancer by testicular ablation or total androgen blockade. The Canadian Anandron Study Group. Cancer Treat Res; 1992; 59():29-40. PubMed ID: 1347692 [No Abstract] [Full Text] [Related]
14. Current treatment of advanced prostate cancer. Ismail M; Gomella LG Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220 [TBL] [Abstract][Full Text] [Related]
15. The utility of prostate-specific antigen in the management of advanced prostate cancer. Crawford ED; Bennett CL; Andriole GL; Garnick MB; Petrylak DP BJU Int; 2013 Sep; 112(5):548-60. PubMed ID: 23826876 [TBL] [Abstract][Full Text] [Related]
16. [Hormone therapy in advanced and generalized carcinoma of the prostate]. Vachalovský V; Dvorácek J; Voboril V Cas Lek Cesk; 1998 Aug; 137(17):532-6. PubMed ID: 9787507 [TBL] [Abstract][Full Text] [Related]
17. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer. Climent MA; Piulats JM; Sánchez-Hernández A; Arranz JÁ; Cassinello J; García-Donas J; González del Alba A; León-Mateos L; Mellado B; Méndez-Vidal MJ; Pérez-Valderrama B; Crit Rev Oncol Hematol; 2012 Sep; 83(3):341-52. PubMed ID: 22285697 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged? Singer EA; Golijanin DJ; Messing EM Can J Urol; 2008 Dec; 15(6):4381-7. PubMed ID: 19046491 [TBL] [Abstract][Full Text] [Related]
19. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management]. Wisard M; Gabellon S Rev Med Suisse Romande; 1995 Mar; 115(3):241-7. PubMed ID: 7777765 [No Abstract] [Full Text] [Related]
20. Hormonal ablation therapy for metastatic prostatic carcinoma: a review. Leewansangtong S; Soontrapa S J Med Assoc Thai; 1999 Feb; 82(2):192-205. PubMed ID: 10087729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]